PHI with paranasal sinusitis
How does this condition affect your private health insurance?
Nebenhöhlenvereiterung, commonly known as sinusitis, is an inflammation or infection of the tissue lining the paranasal sinuses, often triggered by viruses, bacteria, or fungi. It typically follows a common cold or allergic reaction, leading to mucus buildup and pressure. Symptoms include facial pain or pressure, nasal congestion, headache, post-nasal drip, and sometimes fever. While acute sinusitis often resolves with conservative treatment, chronic forms can persist for months, significantly impacting quality of life. Complications, though rare, can include orbital cellulitis or intracranial infections, especially if left untreated.
PKV Risk Assessment
Impact on Your Insurance Policy
Duration of Illness (Initial)
Typically 1-4 weeks for acute cases; can be longer if untreated or complicated.
Duration of Illness (Lifetime)
Can be a one-time event, recurrent (multiple episodes per year), or chronic (lasting over 12 weeks).
Cost of Treatment (Initial)
Low (e.g., 50-300 USD) for acute, uncomplicated cases involving OTC medications, doctor visits, and potentially antibiotics. Higher for specialist consultations or imaging.
Cost of Treatment (Lifetime)
Varies significantly; from minimal for infrequent acute episodes to several thousands for chronic cases requiring repeated specialist care, imaging, and potentially surgery (e.g., FESS).
Mortality Rate
Extremely low (<0.01%) in uncomplicated cases. Rises slightly with rare, severe complications like intracranial spread, but remains very low.
Risk of Secondary Damages
Low (e.g., 5-15%) for general discomfort like chronic headaches, fatigue, or impaired smell. Higher for rare but severe complications like orbital cellulitis or osteomyelitis (<1%).
Probability of Full Recovery
High (e.g., >90%) for acute sinusitis with appropriate treatment. Lower for chronic sinusitis without interventions, potentially 50-70% with treatment.
Underlying Disease Risk
High (e.g., >80%) for a preceding viral upper respiratory infection (common cold). Moderate (e.g., 20-40%) for allergies, nasal polyps, or anatomical abnormalities contributing to recurrent/chronic forms.